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PDZ domain containing 1 (PDZK1) is a scaffold protein that organizes a transportsome and regulates
several transporters' functions including urate and drug transporters. Therefore, PDZK1 in renal proximal
tubules may affect serum uric acid levels through PDZK1-binding renal urate transporters. Two previous
studies in Japanese male population reported that a PDZK1 single nucleotide polymorphism (SNP),
rs12129861, was not associated with gout. In the present study, we performed a further association
analysis between gout and rs12129861 in a different large-scale Japanese male population and a meta-
analysis with previous Japanese population studies. We genotyped rs12129861 in 1210 gout cases and
1224 controls of a Japanese male population by TaqMan assay. As a result, we showed that rs12129861
was signiﬁcantly associated with gout susceptibility (P ¼ 0.016, odds ratio [OR] ¼ 0.80, 95% conﬁdence
interval [CI] 0.67e0.96). The result of the meta-analysis among Japanese populations also showed a
signiﬁcant association (P ¼ 0.013, OR ¼ 0.85, 95%CI 0.75e0.97). Our ﬁndings show the signiﬁcant as-
sociation between gout susceptibility and common variant of PDZK1 which reportedly regulates the
functions of urate transporters in the urate transportsome.
© 2016 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
PDZ domain containing 1 (PDZK1) is a scaffold protein that
binds to various transporters including drug transporters [1e3]. An
example of such transporters is the organic anion transporting
polypeptide 1A2 (OATP1A2), which is expressed in kidney and
functions as a drug transporter [4]. In this scenario, PDZK1 regu-
lates the transport function of OATP1A2 by modulating protein
internalization via a clathrin-dependent pathway and by enhancing
protein stability [1]..
uted equally to this work.
y of Xenobiotics. Published by ElFrom a different perspective, rs12129861, a single nucleotide
polymorphism (SNP), was reported to be associated with serum
uric acid (SUA) levels in a genome-wide association study [5].
Rs12129861 is located near PDZK1 (approximately 2 kb upstream)
and may affect the gene expression levels of PDZK1. However, in
previous Japanese population reports [6,7] of clinically-deﬁned
male gout cases, rs12129861 has not shown a signiﬁcant associa-
tion with gout susceptibility.
In this study, we performed a further association study between
gout and rs12129861 in a different large-scale Japanese population
and a meta-analysis with previous Japanese population reports
[6,7].sevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Meta-analysis of PDZK1 rs12129861 polymorphism for gout in Japanese male
populations. The meta-analysis was performed among results of the present and two
previous Japanese male population studies (Urano et al., 2013 [6] and Takada et al.,
2014 [7]) by the random-effects (DerSimonian and Laird) model. The sizes of the black
boxes are proportional to the inverse of the squared standard error. The horizontal
lines indicate the 95% CIs of ORs. The diamond shows the summary OR, and the width
indicates the 95% CI. The summary OR was 0.85 (95% CI, 0.75e0.97), which was sta-
tistically signiﬁcant (Pmeta ¼ 0.013). CI, conﬁdence interval; OR, odds ratio.
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2.1. Patients and controls
This study was approved by the institutional ethical committees
(National Defense Medical College and Nagoya University). All
procedures were performed in accordance with the Declaration of
Helsinki, and written informed consent was obtained from each
subject participating in the study. From the outpatients of Ryou-
goku East Gate Clinic (Tokyo, Japan), 1210 male Japanese patients
with primary gout were recruited. All the patients were diagnosed
with gout according to the criteria established by the American
College of Rheumatology [8]. As the control group, 1224 Japanese
men without gout history or hyperuricemia (SUA levels > 7.0 mg/
dL) were selected from participants in the Shizuoka area in the
JapanMulti-Institutional Collaborative Cohort Study (J-MICC Study)
[9,10]. The mean age of cases and controls was 45.3 ± 10.4 and
53.1 ± 8.8 years old, respectively, and their mean body-mass index
was 25.4 ± 3.7 and 23.3 ± 2.7 kg/m2, respectively.
2.2. Genetic and statistical analyses
Genomic DNA was extracted from whole peripheral blood as
previously described [11]. Genotyping of the PDZK1 polymorphism
(rs12129861) was performed using a TaqMan assay (Thermo Fisher
Scientiﬁc Inc., Waltham, MA) as previously described [7]. All of
statistical analyses were performed with SPSS v.22.0J (IBM Japan
Inc., Tokyo, Japan) and the software R (version 3.1.1) [12] with meta
package [13]. Chi-square test was used for association and Har-
dyeWeinberg equilibrium analyses. A meta-analysis among pre-
sent and previous studies [6,7] was performed by the DerSimonian
and Laird [14] random-effects model. Cochran's Q test and I2 were
used as measurements of heterogeneity among the present and
two previous [6,7] studies. A P value < 0.05 was considered sta-
tistically signiﬁcant.
3. Results
The rs12129861 of PDZK1 genotyping results for 1210 gout cases
and 1224 controls are shown in Table 1. The genotyping call rate for
rs12129861 was 99.3%. In the control group, this variant was in
HardyeWeinberg equilibrium (P > 0.05).
In contrast to previous Japanese studies' results [6,7], the pre-
sent study shows a statistically signiﬁcant association between
gout and rs12129861 (P ¼ 0.016, odds ratio (OR) with 95% conﬁ-
dence interval (CI) 0.80 [0.67e0.96]). In the meta-analysis among
the present and previous [6,7] Japanese studies, no apparent het-
erogeneity was observed (P value for Cochran's Q test ¼ 0.65,
I2 ¼ 0%), and rs12129861 also showed a signiﬁcant associationwith
gout (Pmeta ¼ 0.013, OR with 95% CI: 0.85 [0.75e0.97]; Fig. 1).
4. Discussion
As a component of a transportsome, PDZK1 regulates the
function of several transporters including drug [1e3] and urateTable 1
Association between gout and the PDZK1 rs12129861 polymorphism.
Genotype Allele frequency mode
G/G G/A A/A MAF P value OR (95% CI)
Case 972 212 14 0.10 0.016 0.80 (0.67e0.96)
Control 939 261 18 0.12
CI, conﬁdence interval; MAF, minor allele frequency; OR, odds ratio.transporters [15e17]. A transportsome is a transporting multimo-
lecular complex composed of transporters and scaffold proteins
[15e17]. In human kidney, the urate transportsome is located at the
apical membrane of proximal tubular cells and contains several
urate transporters [15e17], such as ATP-binding cassette trans-
porter, subfamily G, member 2 (ABCG2/BCRP), organic anion
transporter 4 (OAT4/SLC22A11), urate transporter 1 (URAT1/
SLC22A12), type 1 sodium-dependent phosphate transporter
(NPT1/SLC17A1), and multidrug resistance protein 4 (MRP4/
ABCC4). Common variants of ABCG2 [18] signiﬁcantly increase gout
[19e21] and hyperuricemia risks [22,23]. Additionally, OAT4 [24],
URAT1 [25e28], and NPT1 [27e30] genes are associated with gout
susceptibility. PDZK1 and sodium protein exchanger regulatory
factor 1 (NHERF 1) assemble the scaffolding network connecting
these transporters in the transportsome [16,17].
To date, two previous reports showed lack of association be-
tween the PDZK1 rs12129861 polymorphism and gout suscepti-
bility in the Japanese population; however, as shown in Fig. 1, the
direction of the effect was similar in both studies [6,7]. Therefore,
we performed an additional association analysis in a different
larger Japanese population. A signiﬁcant association between
rs12129861 and gout susceptibility was evidenced by the present
replication study and themeta-analysis with previous reports [6,7].
These ﬁndings imply that lack of association between rs12129861
and gout susceptibility was due to the limited number of samples in
the previous studies [6,7]. Moreover, other studies report the as-
sociation between gout and PDZK1 polymorphisms in Han Chinese
[27,31] and New Zealand population [28]. Two of these reports
[28,31] showed positive association consistently with the present
study results. Since previous genome-wide association studies
showed that common variant of PDZK1 are associated with SUA
[5,32], PDZK1 variants could be associated with gout susceptibility
because of individual differences in SUA levels.
In conclusion, the PDZK1 rs12129861 showed the association
with gout susceptibility which might lead to individual differences
in urate transport through the urate transportsome. Our ﬁndings
also suggest that this PDZK1 variant might be associated with in-
dividual differences in drug transport through the drug
transportsome.Conﬂict of interest
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